Dr. Jessica M. Schuster
Claim this profileWilliam S Middleton VA Medical Center
Studies Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
6 drugs studied
Area of expertise
1Cancer
p16 positive
p16 negative
Stage IV
2Non-Small Cell Lung Cancer
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Jessica M. Schuster is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
More about Jessica M. Schuster
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jessica M. Schuster has experience with
- Atezolizumab
- Stereotactic Body Radiation Therapy
- Cisplatin
- Radiation Therapy
- Apalutamide
- Targeted Radiation Therapy
Breakdown of trials Jessica M. Schuster has run
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jessica M. Schuster specialize in?
Jessica M. Schuster focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved p16 positive patients, or patients who are p16 negative.
Is Jessica M. Schuster currently recruiting for clinical trials?
Yes, Jessica M. Schuster is currently recruiting for 2 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Jessica M. Schuster has studied deeply?
Yes, Jessica M. Schuster has studied treatments such as Atezolizumab, Stereotactic Body Radiation Therapy, Cisplatin.
What is the best way to schedule an appointment with Jessica M. Schuster?
Apply for one of the trials that Jessica M. Schuster is conducting.
What is the office address of Jessica M. Schuster?
The office of Jessica M. Schuster is located at: William S Middleton VA Medical Center, Madison, Wisconsin 53705 United States. This is the address for their practice at the William S Middleton VA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.